Momotow J, Buhnen I, Trautmann-Grill K, Kobbe G, et al. Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis. Br J Haematol 2022 May 11. doi: 10.1111/bjh.18231.
PMID: 35538912